Clinical Trial Update: Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) [Phase 3]

View source ↗

Summary

Phase 3 trial update for mesalamine 4 g sachet used to induce remission in active, mild to moderate ulcerative colitis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• mesalamine 4 g sachet (mesalamine)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2021-03-15